rs557940021
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004823.3(KCNK6):c.149G>A(p.Arg50His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000501 in 1,558,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004823.3 missense
Scores
Clinical Significance
Conservation
Publications
- Kaya-Barakat-Masson syndromeInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152250Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000652 AC: 11AN: 168730 AF XY: 0.0000530 show subpopulations
GnomAD4 exome AF: 0.0000491 AC: 69AN: 1405946Hom.: 0 Cov.: 31 AF XY: 0.0000416 AC XY: 29AN XY: 697014 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74504 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.149G>A (p.R50H) alteration is located in exon 1 (coding exon 1) of the KCNK6 gene. This alteration results from a G to A substitution at nucleotide position 149, causing the arginine (R) at amino acid position 50 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at